Hai-Di Li
Impact in
- Nephrology top 2%
- Acute Kidney Injury Research
- Chronic Kidney Disease and Diabetes
-
- Chemotherapy-induced organ toxicity mitigation
Papers in
-
- Epigenetics and DNA Methylation 5
- Epidemiology 17
- Liver Disease Diagnosis and Treatment 15
- Co-authors
- Xiao‐Ming Meng (33 shared papers)Jun Li (21 shared papers)Li Gao (8 shared papers)Weifeng Wu (7 shared papers)Qin Yang (7 shared papers)Cheng Huang (13 shared papers)Xiongwen Lv (8 shared papers)Cheng Huang (11 shared papers)
In The Last Decade
Hai-Di Li
49 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 106
- Nephrology 369
- Pathology and Forensic Medicine 317
- Hepatology 130
- Pharmacology 135
- Cancer Research 220
Countries citing papers authored by Hai-Di Li
This map shows the geographic impact of Hai-Di Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai-Di Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai-Di Li more than expected).
Fields of papers citing papers by Hai-Di Li
This network shows the impact of papers produced by Hai-Di Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai-Di Li. The network helps show where Hai-Di Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Hai-Di Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 161 | |
| 2 | 2018 | 101 | |
| 3 | 2016 | 79 | |
| 4 | 2018 | 79 | |
| 5 | 2022 | 77 | |
| 6 | 2017 | 73 | |
| 7 | 2020 | 68 | |
| 8 | 2020 | 64 | |
| 9 | 2018 | 61 | |
| 10 | 2019 | 60 | |
| 11 | 2021 | 53 | |
| 12 | 2019 | 53 | |
| 13 | 2017 | 53 | |
| 14 | 2018 | 53 | |
| 15 | 2018 | 45 | |
| 16 | 2020 | 42 | |
| 17 | 2021 | 39 | |
| 18 | 2017 | 36 | |
| 19 | 2019 | 36 | |
| 20 | 2017 | 31 |
About Hai-Di Li
Hai-Di Li is a scholar working on Molecular Biology, Epidemiology, Nephrology, Pathology and Forensic Medicine and Hepatology, having authored 50 papers that have together received 1.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (15 papers), Alcohol Consumption and Health Effects (9 papers), Chronic Kidney Disease and Diabetes (9 papers), Acute Kidney Injury Research (8 papers), Liver physiology and pathology (7 papers), Epigenetics and DNA Methylation (5 papers), Chemotherapy-induced organ toxicity mitigation (4 papers) and Pain Mechanisms and Treatments (3 papers). The work is most often cited by research in Nephrology (369 citations), Pathology and Forensic Medicine (317 citations), Hepatology (130 citations), Pharmacology (135 citations) and Cancer Research (220 citations). Hai-Di Li has collaborated with scholars based in China, Hong Kong and Thailand. Frequent co-authors include Xiao‐Ming Meng, Jun Li, Li Gao, Weifeng Wu, Qin Yang, Cheng Huang, Xiongwen Lv, Cheng Huang, Haiyong Chen and Gui‐Ling Ren. Their work appears in journals such as International Immunopharmacology, Laboratory Investigation, Frontiers in Pharmacology, Frontiers in Immunology and Clinical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.